This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, Y.-W. Articles by Lee, H. Search for Related Content PubMed PubMed Citation Articles by Cheng, Y.-W. Articles by Lee, H.

The Association of Human Papillomavirus 16/18 Infection with Lung Cancer among Nonsmoking Taiwanese Women¹

Institute of Medicine [Y-W. C., H. L.], Institute of Toxicology [H. L., G-T. S.], and Departments of Medical Technology [H-L. C.], and Thoracic Surgery [J-M. S.], Chung Shan Medical and Dental College, Taichung; Departments of Pathology [J-T. C.], and Thoracic Surgery [C-Y. C.], Veterans General Hospital-Taichung, Taichung; and Department of Public Health, Chang Gung University, Tao-Yuan [L-L. H.], Taiwan, Republic of China

Lung cancer is the leading cause of cancer death in Taiwanese women since 1982. High lung cancer mortality ratio of male:female in Taiwan (2:1) was observed, although less than 10% of female lung cancer patients are smokers. Until now, the etiological factor remains unknown. We hypothesize that high-risk human papillomavirus (HPV) 16/18 may be associated with lung cancer development based on high prevalence of p53 negative immunostainings in female lung tumors compared with that of male lung tumors. In this study, 141 lung cancer patients and 60 noncancer control subjects were enrolled to examine whether HPV 16/18 DNA existed in lung tumor and normal tissues by nested PCR and in situ hybridization (ISH), respectively. The concordant detection of HPV 16 and 18 DNA between nested PCR and ISH method was 73 and 85.5%, respectively. Our data showed that 77 (54.6%) of 141 lung tumors had HPV 16/18 DNA compared with 16 (26.7%; P = 0.0005) of 60 noncancer control subjects. In addition, ISH data showed that HPV 16/18 DNA was uniformly located in lung tumor cells, but not in the adjacent nontumor cells. When study subjects were stratified by gender, age, and smoking status, nonsmoking female lung cancer patients who were older than 60 years old had significantly high prevalence of HPV 16/18 infection. The odds ratio of HPV 16/18 infection of nonsmoking female lung cancer patients is much higher at 10.12 (95% confidence interval, 3.88–26.38) compared with 1.98 (95% confidence interval, 0.84–4.76) of nonsmoking male lung cancer patients. This result strongly suggests that HPV infection is associated with lung cancer development of nonsmoking female lung cancer patients. The high prevalence of HPV 16/18 infection may explain to a certain extent why Taiwanese women nonsmokers had a higher lung cancer mortality rate.

This article has been cited by other articles:

				C.-W. Wang, T.-I Wu, C.-T. Yu, Y.-C. Wu, Y.-H. Teng, S.-Y. Chin, C.-H. Lai, and T.-C. Chen Usefulness of p16 for Differentiating Primary Pulmonary Squamous Cell Carcinoma From Cervical Squamous Cell Carcinoma Metastatic to the Lung Am J Clin Pathol, May 1, 2009; 131(5): 715 - 722. [Abstract] [Full Text] [PDF]

				S. Roperto, R. Brun, F. Paolini, C. Urraro, V. Russo, G. Borzacchiello, U. Pagnini, C. Raso, C. Rizzo, F. Roperto, et al. Detection of bovine papillomavirus type 2 in the peripheral blood of cattle with urinary bladder tumours: possible biological role J. Gen. Virol., December 1, 2008; 89(12): 3027 - 3033. [Abstract] [Full Text] [PDF]

				Y.-W. Cheng, T.-C. Wu, C.-Y. Chen, M.-C. Chou, J.-L. Ko, and H. Lee Human Telomerase Reverse Transcriptase Activated by E6 Oncoprotein Is Required for Human Papillomavirus-16/18-Infected Lung Tumorigenesis Clin. Cancer Res., November 15, 2008; 14(22): 7173 - 7179. [Abstract] [Full Text] [PDF]

				Q. Jin, D. G. Menter, L. Mao, W. K. Hong, and H.-Y. Lee Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure Carcinogenesis, August 1, 2008; 29(8): 1614 - 1622. [Abstract] [Full Text] [PDF]

				Y.-W. Cheng, H. Lee, M.-Y. Shiau, T.-C. Wu, T.-T. Huang, and Y.-H. Chang Human Papillomavirus Type 16/18 Up-Regulates the Expression of Interleukin-6 and Antiapoptotic Mcl-1 in Non-Small Cell Lung Cancer Clin. Cancer Res., August 1, 2008; 14(15): 4705 - 4712. [Abstract] [Full Text] [PDF]

				Y.-W. Cheng, M.-F. Wu, J. Wang, K.-T. Yeh, Y.-G. Goan, H.-L. Chiou, C.-Y. Chen, and H. Lee Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation Cancer Res., November 15, 2007; 67(22): 10686 - 10693. [Abstract] [Full Text] [PDF]

				C.-K. Toh and W.-T. Lim Lung cancer in never-smokers J. Clin. Pathol., April 1, 2007; 60(4): 337 - 340. [Full Text] [PDF]

				A. F. Gazdar and M. J. Thun Lung Cancer, Smoke Exposure, and Sex J. Clin. Oncol., February 10, 2007; 25(5): 469 - 471. [Full Text] [PDF]

				J. Subramanian and R. Govindan Lung Cancer in Never Smokers: A Review J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570. [Abstract] [Full Text] [PDF]

				J Cadranel, D Garfield, A Lavole, M Wislez, B Milleron, and C Mayaud Lung cancer in HIV infected patients: facts, questions and challenges. Thorax, November 1, 2006; 61(11): 1000 - 1008. [Abstract] [Full Text] [PDF]

				C.-K. Toh, F. Gao, W.-T. Lim, S.-S. Leong, K.-W. Fong, S.-P. Yap, A. A.L. Hsu, P. Eng, H.-N. Koong, A. Thirugnanam, et al. Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity J. Clin. Oncol., May 20, 2006; 24(15): 2245 - 2251. [Abstract] [Full Text] [PDF]

				Y. Fei, J. Yang, W.-C. Hsieh, J.-Y. Wu, T.-C. Wu, Y.-G. Goan, H. Lee, and Y.-W. Cheng Different Human Papillomavirus 16/18 Infection in Chinese Non-Small Cell Lung Cancer Patients Living in Wuhan, China Jpn. J. Clin. Oncol., May 1, 2006; 36(5): 274 - 279. [Abstract] [Full Text] [PDF]

				S. Bodaghi, L. V. Wood, G. Roby, C. Ryder, S. M. Steinberg, and Z.-M. Zheng Could Human Papillomaviruses Be Spread through Blood? J. Clin. Microbiol., November 1, 2005; 43(11): 5428 - 5434. [Abstract] [Full Text] [PDF]

				L. Thomas, L. A. Doyle, and M. J. Edelman Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy Chest, July 1, 2005; 128(1): 370 - 381. [Abstract] [Full Text] [PDF]

				T.-Y. Chou, C.-H. Chiu, L.-H. Li, C.-Y. Hsiao, C.-Y. Tzen, K.-T. Chang, Y.-M. Chen, R.-P. Perng, S.-F. Tsai, and C.-M. Tsai Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non-Small Cell Lung Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3750 - 3757. [Abstract] [Full Text] [PDF]

				S. Bodaghi, K. Yamanegi, S.-Y. Xiao, M. Da Costa, J. M. Palefsky, and Z.-M. Zheng Colorectal Papillomavirus Infection in Patients with Colorectal Cancer Clin. Cancer Res., April 15, 2005; 11(8): 2862 - 2867. [Abstract] [Full Text] [PDF]

				W. Pao and V. A. Miller Epidermal Growth Factor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non-Small-Cell Lung Cancer: Current Knowledge and Future Directions J. Clin. Oncol., April 10, 2005; 23(11): 2556 - 2568. [Abstract] [Full Text] [PDF]

				H. Shigematsu, L. Lin, T. Takahashi, M. Nomura, M. Suzuki, I. I. Wistuba, K. M. Fong, H. Lee, S. Toyooka, N. Shimizu, et al. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers J Natl Cancer Inst, March 2, 2005; 97(5): 339 - 346. [Abstract] [Full Text] [PDF]

				T. Kosaka, Y. Yatabe, H. Endoh, H. Kuwano, T. Takahashi, and T. Mitsudomi Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer: Biological and Clinical Implications Cancer Res., December 15, 2004; 64(24): 8919 - 8923. [Abstract] [Full Text] [PDF]

				J. D. Patel, P. B. Bach, and M. G. Kris Lung Cancer in US Women: A Contemporary Epidemic JAMA, April 14, 2004; 291(14): 1763 - 1768. [Abstract] [Full Text] [PDF]

				K M Fong, Y Sekido, A F Gazdar, and J D Minna Lung cancer * 9: Molecular biology of lung cancer: clinical implications Thorax, October 1, 2003; 58(10): 892 - 900. [Abstract] [Full Text] [PDF]

				M. L. Gillison and K. V. Shah Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 57 - 65. [Abstract] [Full Text] [PDF]

				K J Syrjanen HPV infections and lung cancer J. Clin. Pathol., December 1, 2002; 55(12): 885 - 891. [Abstract] [Full Text] [PDF]

				D. Kenny, L.-P. Shen, and J. A. Kolberg Detection of Viral Infection and Gene Expression in Clinical Tissue Specimens Using Branched DNA (bDNA) In Situ Hybridization J. Histochem. Cytochem., September 1, 2002; 50(9): 1219 - 1227. [Abstract] [Full Text] [PDF]